Cita APA

Campistol Plana, J. M., González Duarte, A., Suhr, O. B., Goyal, S., Gandhi, P. J., Polydefkis, M., . . . Gollob, J. A. (2018). Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis.

Citación estilo Chicago

Campistol Plana, Josep M., et al. Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis. 2018.

Cita MLA

Campistol Plana, Josep M., et al. Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis. 2018.